Brief: Scinai Immunotherapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

Scinai Immunotherapeutics

07/06/2024 12:34

June 7 (Reuters) - Scinai Immunotherapeutics Ltd
 2F5y.F :
    * SCINAI IMMUNOTHERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ
MINIMUM
BID PRICE REQUIREMENT; CONTINUES TO WORK WITH THE EUROPEAN
INVESTMENT BANK TO CONVERT LOAN TO EQUITY TO REGAIN COMPLIANCE
WITH NASDAQ MINIMUM SHAREHOLDERS' EQUITY REQUIREMENT
    * SCINAI IMMUNOTHERAPEUTICS LTD - ENGAGED IN DISCUSSIONS
WITH
EUROPEAN INVESTMENT BANK REGARDING AMENDING FINANCE CONTRACT
WITH EIB

Source text for Eikon:  ID:nPn4ZmYY7a 
Further company coverage:  2F5y.F 

 ((Reuters.Briefs@thomsonreuters.com;))